Vivek Sulekha Radhakrishnan

8PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 17, 2024
Chimeric Antigen Receptor T-cell based cellular therapies for cancer: An introduction and Indian perspective.

Reena J Rathod, Reghu K Sukumaran, Neelam Kedia

|Feb 16, 2023
Expert consensus on the management of chronic lymphocytic leukaemia in Asia.

Eric Tse, Yok Lam Kwong, Yeow Tee Goh

|Jan 02, 2023
Salvage Using Polatuzumab Vedotin Based Therapy in Relapsed Refractory Large B-Cell Lymphomas: Early Experience from a Real-World Middle-Income Setting Using Named-Patient Compassionate Access Program.

V S Radhakrishnan, R Pincha, V Raina

|May 02, 2022
Primary Central Nervous System Lymphoma: Long-Term Treatment Outcomes and Cost-Analysis from a Retrospective Study of High-Dose Methotrexate Based Chemoimmunotherapy and Reduced Dose Radiation Therapy Approach.

Radhakrishnan Vs, Podder D, Mukherjee H

|Nov 25, 2021
Mantle cell lymphoma: A clinical review of the changing treatment paradigms with the advent of novel therapies, and an insight into Indian data.

Vivek Sulekha Radhakrishnan, Padmaja Lokireddy, Mayur Parihar

|Feb 18, 2021
Relapsed plasmablastic lymphoma in a HIV-negative patient: Pushing the envelope.

Manthan Kathrotiya, Vivek S Radhakrishnan, Saurabh J Bhave

Pageof 2

Frequent Collaborators

1 joint publications

Rizwan Javed

1 joint publications

Eric Tse

1 joint publications

Yok Lam Kwong

1 joint publications

Yeow Tee Goh